Growth Metrics

Lexicon Pharmaceuticals (LXRX) Non-Current Deffered Revenue: 2009-2011

Historic Non-Current Deffered Revenue for Lexicon Pharmaceuticals (LXRX) over the last 3 years, with Dec 2011 value amounting to $14.2 million.

  • Lexicon Pharmaceuticals' Non-Current Deffered Revenue fell 2.12% to $13.9 million in Q3 2012 from the same period last year, while for Sep 2012 it was $13.9 million, marking a year-over-year decrease of 2.12%. This contributed to the annual value of $14.2 million for FY2011, which is negligibly% changed negligibly from last year.
  • As of FY2011, Lexicon Pharmaceuticals' Non-Current Deffered Revenue stood at $14.2 million, which was down 0.00% from $14.2 million recorded in FY2010.
  • In the past 5 years, Lexicon Pharmaceuticals' Non-Current Deffered Revenue ranged from a high of $14.2 million in FY2009 and a low of $14.2 million during FY2009.
  • Over the past 3 years, Lexicon Pharmaceuticals' median Non-Current Deffered Revenue value was $14.2 million (recorded in 2011), while the average stood at $14.2 million.